Orthofix Medical (OFIX) Metrics: History & Chart

Orthofix Medical Inc.(OFIX)

Medical - Devices · Lewisville, TX

$9.41-0.09 (-0.95%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Orthofix Medical Inc.

Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics. Its reach extends across the United States, several European nations including Italy, Germany, France, and the United Kingdom, as well as Brazil and other international markets. The company's operations are divided into two main segments: Global Spine and Global Orthopedics. Within the Global Spine division, Orthofix is responsible for the development, production, and distribution of bone growth stimulators. These devices are designed to facilitate bone fusion and serve as a therapeutic intervention for fractures located outside the spine and in the limbs. This segment also creates and commercializes a range of motion preservation and fixation implant products utilized in spinal surgical procedures. Furthermore, it supplies physicians with various tissue forms and synthetic-based regenerative biologic solutions to address a wide spectrum of spinal and orthopedic conditions. The Global Orthopedics segment concentrates on the design, development, and commercialization of specialized orthopedic products. These offerings are essential for procedures involving fracture repair, the correction of deformities, and bone reconstruction. Orthofix distributes its products to a diverse clientele, including physicians, hospitals, outpatient surgery centers, and integrated health delivery systems. This is achieved through a comprehensive sales network that includes its own sales force, independent distributors, and both employed and external sales representatives. The company, previously known as Orthofix International N.V., officially changed its name to Orthofix Medical Inc. in July 2018.

Lewisville, TX

1,605 employees

www.orthofix.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Massimo Calafiore

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-3.46%
30D Total Return	+2.26%
YTD Total Return	-37.34%
1Y Total Return	-34.98%
3Y Total Return	-19.36%
5Y Total Return	-74.59%
10Y Total Return	-76.57%
15Y Total Return	-71.74%
20Y Total Return	-79.06%

2026	-37.34%
2025	-13.17%
2024	+29.53%
2023	-34.34%
2022	-33.97%
2021	-27.66%
2020

CAGR TTM	-34.84%
CAGR 3Y	-6.92%
CAGR 5Y	-23.97%
CAGR 10Y	-13.51%
CAGR 15Y	-8.08%
CAGR 20Y	-7.52%

PE Ratio	369.58
PE Ratio Avg TTM	157.27
PE Ratio Avg 3Y	98.07
Current VS TTM Avg	+135.00%
Current VS 3Y Avg	+276.85%
Current VS 5Y Avg	+234.81%

All Metrics

OFIX Valuation Metrics

OFIX Stock Price Metrics

OFIX Dividend Metrics

OFIX Growth Rate Metrics

OFIX Discounted Cash Flow Metrics

OFIX Returns By Period

OFIX Yearly Returns

OFIX Average Annual Returns By Period (CAGR)

OFIX Revenue Metrics

OFIX PE Ratio Metrics

OFIX PS Ratio Metrics

OFIX PB Ratio Metrics

OFIX Price to Free Cash Flow Ratio Metrics

OFIX Debt to Equity Ratio Metrics

OFIX PEG Ratio Metrics

OFIX FCF Yield

OFIX Earnings Yield

OFIX EBITDA Yield

OFIX OCF Yield

OFIX EV/EBIT Ratio Metrics

OFIX EV/EBITDA Ratio Metrics

OFIX EV/Assets Ratio Metrics

OFIX EV/Sales Ratio Metrics

OFIX Current Ratio Metrics

OFIX Quick Ratio Metrics

OFIX ROIC Metrics

OFIX Return on Assets Metrics

OFIX Return on Equity Metrics

OFIX Net Profit Margin Metrics

OFIX Gross Profit Margin Metrics

OFIX Tax Rate Metrics

PS Ratio	0.47
PS Ratio Avg TTM	0.60
PS Ratio Avg 3Y	0.69
Current VS TTM Avg	-22.24%
Current VS 3Y Avg	-31.79%
Current VS 5Y Avg	-42.34%

PB Ratio	0.91
PB Ratio Avg TTM	1.12
PB Ratio Avg 3Y	1.06
Current VS TTM Avg	-18.98%
Current VS 3Y Avg	-14.21%
Current VS 5Y Avg	-20.23%

PFCF Ratio	1274.11
PFCF Ratio Avg TTM	1259.76
PFCF Ratio Avg 3Y	1259.76
Current VS TTM Avg	+1.14%
Current VS 3Y Avg	+1.14%
Current VS 5Y Avg	+4660.53%

Debt/Equity Ratio	0.55
Debt/Equity Ratio Avg TTM	0.50
Debt/Equity Ratio Avg 3Y	0.35
Current VS TTM Avg	+9.18%
Current VS 3Y Avg	+57.32%
Current VS 5Y Avg	+127.09%

PEG Ratio	92.06
PEG Ratio Avg TTM	0.33
PEG Ratio Avg 3Y	0.34
Current VS TTM Avg	+27624.20%
Current VS 3Y Avg	+27051.24%
Current VS 5Y Avg	+27051.24%

FCF Yield	0.08%
FCF Yield Avg TTM	0.08%
FCF Yield Avg 3Y	0.08%
Current VS TTM Avg	-0.00%
Current VS 3Y Avg	-0.00%
Current VS 5Y Avg	-97.94%

Earnings Yield	0.27%
Earnings Yield Avg TTM	1.96%
Earnings Yield Avg 3Y	0.91%
Current VS TTM Avg	-86.22%
Current VS 3Y Avg	-70.29%
Current VS 5Y Avg	-67.93%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	125.30
Ev/Ebit Ratio Avg TTM	99.68
Ev/Ebit Ratio Avg 3Y	74.66
Current VS TTM Avg	+25.70%
Current VS 3Y Avg	+67.83%
Current VS 5Y Avg	+223.59%

Ev/Ebitda Ratio	4.34
Ev/Ebitda Ratio Avg TTM	129.81
Ev/Ebitda Ratio Avg 3Y	151.06
Current VS TTM Avg	-96.66%
Current VS 3Y Avg	-97.13%
Current VS 5Y Avg	-68.78%

Ev/Assets Ratio	0.59
Ev/Assets Ratio Avg TTM	0.74
Ev/Assets Ratio Avg 3Y	0.74
Current VS TTM Avg	-20.00%
Current VS 3Y Avg	-20.33%
Current VS 5Y Avg	-25.67%

Ev/Sales Ratio	0.62
Ev/Sales Ratio Avg TTM	0.77
Ev/Sales Ratio Avg 3Y	0.83
Current VS TTM Avg	-19.07%
Current VS 3Y Avg	-25.34%
Current VS 5Y Avg	-30.92%

Current Ratio	2.84
Current Ratio Avg TTM	2.66
Current Ratio Avg 3Y	2.62
Current VS TTM Avg	+6.93%
Current VS 3Y Avg	+8.59%
Current VS 5Y Avg	+2.45%

Quick Ratio	1.67
Quick Ratio Avg TTM	1.55
Quick Ratio Avg 3Y	1.36
Current VS TTM Avg	+7.63%
Current VS 3Y Avg	+22.42%
Current VS 5Y Avg	+6.78%

ROIC	(3.55%)
ROIC Avg 3Y	(14.16%)
ROIC Avg 5Y	(8.75%)
Current VS 3Y Avg	+74.94%
Current VS 5Y Avg	+59.45%
Current VS 10Y Avg	-2.53%

ROA	(7.07%)
ROA Avg TTM	(1.77%)
ROA Avg 3Y	(2.75%)
Current VS TTM Avg	-299.49%
Current VS 3Y Avg	-157.16%
Current VS 5Y Avg	-159.24%

ROE	(14.38%)
ROE Avg TTM	(20.51%)
ROE Avg 3Y	(22.43%)
Current VS TTM Avg	+29.90%
Current VS 3Y Avg	+35.89%
Current VS 5Y Avg	+16.61%

Net Profit Margin	(7.41%)
Net Profit Margin Avg TTM	(7.43%)
Net Profit Margin Avg 3Y	(13.40%)
Current VS TTM Avg	+0.26%
Current VS 3Y Avg	+44.68%
Current VS 5Y Avg	+32.39%

Gross Profit Margin	69.59%
Gross Pft Margin Avg TTM	69.48%
Gross Pft Margin Avg 3Y	67.73%
Current VS TTM Avg	+0.15%
Current VS 3Y Avg	+2.75%
Current VS 5Y Avg	-0.03%

Tax Rate	18.18%
Tax Rate Avg 3Y	(0.61%)
Tax Rate Avg 5Y	45.20%
Current VS 3Y Avg	+3098.28%
Current VS 5Y Avg	-59.78%
Current VS 10Y Avg	-67.94%